DIAH

DIAH 2026

19 – 21 May 2026 | Bruges, Belgium

Speakers

Valerio Abbadessa

Reserach programme officer

EC DG AGRI

Ronaldo Avella Lavado

Business Development, Operations and Regulatory Affairs Manager

Paul Dick & Associations Ltd. (Pda)

Juerg Baggenstoss

Partner

Stonehaven Cozmix Group

Joni Bert

Ghent University - provaxs

Erwin Blomsma

CEO and co-founder

Benno Therapeutics

Stewart Burgess

Moredun Scientific /Moredun Research Institute

Benedict Chambers

CEO

Prodessa Pharmaceuticals

Bryan Charleston

Director and CEO

The Pirbright Institute

Johannes Charlier

Managing director

Kreavet

Laetitia Cicchelero

Cross-Health coordinator

Ghent University - provaxs

Ivo Claassen

European Medicines Agency

Bert Devriendt

professor in immunology

Ghent University - provaxs

Jennifer DI BARTOLO

pharma/biotech strategic collaboration & marketing manager

Promega

Ulrike Diesterbeck

VEROVACCiNES

Anniek Eerdekens

Postdoctoral Researcher

WAVES UGent-imec

Natacha Gaillard

ASTRA Therapeutics

Nicolás Galmarini

CEO & Co-founder

NanoVet Biotech

Jeremy Gowler

CEO

Ophirex, Inc.

Bing Han

Lead High Tech Animal Models

Wageningen Bioveterinary Research

Ashiqul Haque

Quantoom Biosciences

Klaus Hellmann

Head of EU-CRO

ARGENTA

Ralf Herold

European Medicines Agency

Kazuhiko HIROSE

President and Representative Director

Meiji Animal Health Co., Ltd.

Jeroen Hofenk

Chief Scientific Officer

SwiftPharma

Paul Horwood

IVC Evidensia

Endre Kiss-Toth

Founder, CEO

StemcellX Limited

Francisco LePort

CEO

Gordian Biotechnology

Alfonso Martin-Fontecha

Business Development Manager

Laboratorios SYVA

Steve Nanchen

Snr Director, External Innovation

Elanco Animal Health

Charles Owen

CEO / Founder 272BIO

272BIO Limited